AUPH · Company research
Aurinia Pharmaceuticals Inc (AUPH): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 15.69 | $2,383,964,400 | 2204132400.00 | 237.07142857142853 | — | — | 35.1767629221938587 | 3.8772222800489214 | 45.35183198265038237605 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.